Human herpesvirus 6 and drug allergy
- 1 August 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 3 (4) , 255-260
- https://doi.org/10.1097/00130832-200308000-00004
Abstract
The similarity between viral skin eruption and drug-induced rash has inspired many researchers to seek an association between viral infection and drug allergy. Hypersensitivity syndrome (referred to in this review as drug-induced hypersensitivity syndrome) is one of the severe adverse reactions to drugs and was reported more than 50 years ago. However, the mechanism of drug-induced hypersensitivity syndrome has not been fully elucidated. Several groups reported the association between human herpesvirus 6 reactivation and drug-induced hypersensitivity syndrome 5 years ago. Recently, similar case reports have accumulated. Recent findings concerning human herpesvirus 6 and drug-induced hypersensitivity syndrome are reviewed here. In drug-induced hypersensitivity syndrome, examination of serial serum samples revealed a marked and sudden increase in anti-human herpesvirus 6 IgG titers in the third or fourth week after the onset of clinical manifestations. In addition, active human herpesvirus 6 replication precedes the rise in antibody titers. Furthermore, the recurrence or worsening of signs and symptoms was observed concurrently with human herpesvirus 6 reactivation. In encephalitis associated with drug-induced hypersensitivity syndrome, human herpesvirus 6 DNA was detected in cerebrospinal fluid. This strongly indicates the involvement of reactivated human herpesvirus 6 in the pathogenesis of encephalitis. Similarly, reactivation of human herpesvirus 6 was observed in fulminant type 1 diabetes mellitus associated with drug-induced hypersensitivity syndrome caused by carbamazepine. The reactivation of human herpesvirus 6 in drug-induced hypersensitivity syndrome is not a coincidental phenomenon. Human herpesvirus 6 reactivation plays an important role in the pathogenesis of drug-induced hypersensitivity syndrome, especially in the latter half of the clinical symptoms. Reactivated human herpesvirus 6 sometimes leads to the severe complications of drug-induced hypersensitivity syndrome, such as encephalitis and type 1 diabetes mellitus. In conclusion, drug-induced hypersensitivity syndrome is a complex disease composed of drug allergy and human herpesvirus 6.Keywords
This publication has 31 references indexed in Scilit:
- Human herpesvirus‐6 encephalitis associated with hypersensitivity syndromeAnnals of Neurology, 2003
- Analysis of Intravenous Immunoglobulin for the Treatment of Toxic Epidermal Necrolysis Using SCORTENArchives of Dermatology, 2003
- Salazosulfapyridine Induced Hypersensitivity Syndrome Associated with Reactivation of Humanherpes Virus 6.Internal Medicine, 2003
- Phenotypic and Functional Alterations of Dendritic Cells Induced by Human Herpesvirus 6 InfectionJournal of Virology, 2002
- Human herpesvirus 6 encephalitis associated with hypersensitivity syndromeAnnals of Neurology, 2002
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.Journal of Clinical Investigation, 1988
- Immediate hypersensitivity reactions to penicillin and related antibioticsClinical and Experimental Allergy, 1988
- IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUMPublished by Elsevier ,1988
- Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative DisordersScience, 1986